Robert Kolakowski Email & Phone Number
@dicerna.com
2 phones found area 425
LinkedIn matched
Who is Robert Kolakowski? Overview
A concise factual answer block for searchers comparing this professional profile.
Robert Kolakowski is listed as Senior Director, Head of RNAi Chemistry at Novo Nordisk at Novo Nordisk, based in Lexington, Massachusetts, United States. AeroLeads shows a work email signal at dicerna.com, phone signal with area code 425, and a matched LinkedIn profile for Robert Kolakowski.
Robert Kolakowski previously worked as Senior Director of Medicinal Chemistry at Novo Nordisk and Senior Director of Medicinal Chemistry at Dicerna Pharmaceuticals, Inc.. Robert Kolakowski holds Phd, Organic Chemistry from Rutgers University.
Email format at Novo Nordisk
This section adds company-level context without repeating Robert Kolakowski's masked contact details.
AeroLeads found 1 current-domain work email signal for Robert Kolakowski. Compare company email patterns before reaching out.
About Robert Kolakowski
Specialties: oligonucleotide chemistry, oligonucleotide delivery, drug-linkers, conjugation technology, linker methodology, antibody-drug conjugates and protein conjugates for anti-inflammatory, non-oncology and oncology payloads, protein expression and purification.
Listed skills include Medicinal Chemistry, Chemistry, Drug Discovery, Organic Synthesis, and 35 others.
Robert Kolakowski's current company
Company context helps verify the profile and gives searchers a useful next step.
Robert Kolakowski work experience
A career timeline built from the work history available for this profile.
Senior Director Of Medicinal Chemistry
Director Of Chemistry
Associate Director
Senior Scientist, Chemistry
Synthesize chemotypes (payloads), develop linker technology for attachment of payloads to antibody drug conjugates (ADCs), and advance alternative ADC modalities.
Scientist, Chemistry
Synthesize chemotypes (warheads) and develop linker technology for attachment to antibody drug conjugates (ADCs).
Post Doc, Advisor: Peter Senter
The synthesis of PBDs pyrrolobenzodiazepine dimers (PBDs) and their drug linkers.
Post Doc, Advisor: K.C. Nicolaou
Trioxacarcin : Through Lewis Acid Mediated Epoxide Opening
Robert Kolakowski education
-
Rutgers University
Frequently asked questions about Robert Kolakowski
Quick answers generated from the profile data available on this page.
What company does Robert Kolakowski work for?
Robert Kolakowski works for Novo Nordisk.
What is Robert Kolakowski's role at Novo Nordisk?
Robert Kolakowski is listed as Senior Director, Head of RNAi Chemistry at Novo Nordisk at Novo Nordisk.
What is Robert Kolakowski's email address?
AeroLeads has found 1 work email signal at @dicerna.com for Robert Kolakowski at Novo Nordisk.
What is Robert Kolakowski's phone number?
AeroLeads has found 2 phone signal(s) with area code 425 for Robert Kolakowski at Novo Nordisk.
Where is Robert Kolakowski based?
Robert Kolakowski is based in Lexington, Massachusetts, United States while working with Novo Nordisk.
What companies has Robert Kolakowski worked for?
Robert Kolakowski has worked for Novo Nordisk, Dicerna Pharmaceuticals, Inc., Aro Biotherapeutics, Seattle Genetics, and The Scripps Research Institute.
How can I contact Robert Kolakowski?
You can use AeroLeads to view verified contact signals for Robert Kolakowski at Novo Nordisk, including work email, phone, and LinkedIn data when available.
What schools did Robert Kolakowski attend?
Robert Kolakowski holds Phd, Organic Chemistry from Rutgers University.
What skills is Robert Kolakowski known for?
Robert Kolakowski is listed with skills including Medicinal Chemistry, Chemistry, Drug Discovery, Organic Synthesis, Uv/Vis, Drug Development, Oncology, and Organic Chemistry.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial